NSD2 and acute lymphoblastic leukemia: Furthermore, a gain-of-function WHSC1 point mutation (E1099K) has also been identified in pediatric acute lymphoblastic leukemia cell lines resulting in a dependency on mutant WHSC1 activity [16, 17].